Not Tagged
galapagos,CellPoint
['galapagos']
press release: | galapagos and cellpoint presented encouraging initial data at ash 2022 for glpg5101, a cd19 car-t candidate manufactured at point-of-care. #ash22 #pioneeringforpatients #bloodcancer 
?? Global Twitter account | ?? We aim to discover & develop breakthrough therapies for patients | #PioneeringForPatients | Twitter guidelines: https://t.co/XrEF42YjcK